Page 7 - Algorithm for erectile rehabilitation following prostate cancer treatment

consensus: algorithm for erectile rehabilitation after Pca treatment

28. Matthew AG, Goldman A, Trachtenberg J, et al. Sexual dysfunction after radical prostatectomy: 39. Zaider T, Manne S, Nelson C, et al. Loss of masculine identity, marital affection, and sexual bother in
Prevalence, treatments, restricted use of treatments, and distress. J Urol 2005;174:2105-10. men with localized prostate cancer. J Sex Med 2012;9:2724-32. https://doi.org/10.1111/j.1743-
https://doi.org/10.1097/01.ju.0000181206.16447.e2 6109.2012.02897.x
29. Davison BJ, Matthew A, Elliott S, et al. Assessing couples’ preferences for postoperative sexual rehabili- 40. Gannon K, Guerro-Blanco M, Patel A, et al. Re-constructing masculinity following radical prostatectomy for
tation before radical prostatectomy. BJU Int 2012;110:1529-35. https://doi.org/10.1111/j.1464- prostate cancer. Aging Male 2010;13:258-64. https://doi.org/10.3109/13685538.2010.487554
410X.2012.11083.x 41. Wittmann D, Foley S, Balon R. A biopsychosocial approach to sexual recovery after prostate cancer
30. Fisher WA, Eardley I, Mccabe M, et al. Erectile dysfunction (ed) is a shared sexual concern of couples surgery: The role of grief and mourning. J Sex Marital Ther 2011;37:130-44. https://doi.org/10.10
ii: Association of female partner characteristics with male partner ED treatment seeking and phosphodi- 80/0092623X.2011.560538
esterase type 5 inhibitor utilization. J Sex Med 2009;6:3111-24. https://doi.org/10.1111/j.1743- 42. Kim E, Seftel A, Goldfischer E, et al. Comparative efficacy of tadalafil once daily in men with erectile
6109.2009.01432.x dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil.
31. Dunn ME. Restoration of couple’s intimacy and relationship vital to reestablishing erectile function. J Am Curr Med Res Opin 2015;31:379-89. https://doi.org/10.1185/03007995.2014.989317
Osteopath Assoc 2004;104:S6-10. 43. Castiglione F, Nini A, Briganti A. Penile rehabilitation with phosphodiesterase type 5 inhibitors after
32. Jiann BP, Yu CC, Su CC, et al. Rechallenge prior sildenafil non-responders. Int J Impot Res 2004;16:64-8. nerve-sparing radical prostatectomy: Are we targeting the right patients? Eur Urol 2014;65:673-4.
https://doi.org/10.1038/sj.ijir.3901143 2014/01/07. https://doi.org/10.1016/j.eururo.2013.11.049
33. Wittmann D, Carolan M, Given B, et al. What couples say about their recovery of sexual intimacy after 44. Gallina A, Ferrari M, Suardi N, et al. Erectile function outcome after bilateral nerve-sparing radical prosta-
prostatectomy: Toward the development of a conceptual model of couples’ sexual recovery after surgery tectomy: Which patients may be left untreated? J Sex Med 2012;9:903-8. https://doi.org/10.1111/
for prostate cancer. J Sex Med 2015;12:494-504. https://doi.org/10.1111/jsm.12732 j.1743-6109.2011.02622.x
34. Walker LM, Wassersug RJ, Robinson JW. Psychosocial perspectives on sexual recovery after prostate cancer 45. Carvalheira AA, Pereira NM, Maroco J, et al. Dropout in the treatment of erectile dysfunction with pde5: A
treatment. Nat Rev Urol 2015;12:167. https://doi.org/10.1038/nrurol.2015.29 study on predictors and a qualitative analysis of reasons for discontinuation. J Sex Med 2012;9:2361-9.
35. Bella AJ, Lee JC, Carrier S, et al. 2015 CUA practice guidelines for erectile dysfunction. Can Urol Assoc J https://doi.org/10.1111/j.1743-6109.2012.02787.x
2015;9:23-9. https://doi.org/10.5489/cuaj.2699 46. Montorsi F, Brock G, Stolzenburg JU, et al. Effects of tadalafil treatment on erectile function recovery
36. Kimura M, Caso JR, Banez LL, et al. Predicting participation in and successful outcome of a penile rehabilita- following bilateral nerve-sparing radical prostatectomy: A randomized placebo-controlled study (reactt).
tion programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical Eur Urol 2014;65:587-96. https://doi.org/10.1016/j.eururo.2013.09.051
prostatectomy. BJU Int 2012;110:E931-8. https://doi.org/10.1111/j.1464-410X.2012.11168.x 47. Sadovsky R, Brock GB, Gutkin SW, et al. Toward a new ‘epoch’: Optimizing treatment outcomes
37. Defade BP, Carson CC 3rd, Kennelly MJ. Postprostatectomy erectile dysfunction: The role of penile with phosphodiesterase type 5 inhibitors for erectile dysfunction. Int J Clin Pract 2009;63:1214-30.
rehabilitation. Rev Urol 2011;13:6-13. https://doi.org/10.1111/j.1742-1241.2009.02119.x
38. Wiegner EA, King CR. Sexual function after stereotactic body radiotherapy for prostate cancer: Results of
a prospective clinical trial. Int J Radiat Oncol Biol Phys 2010;78:442-8. https://doi.org/10.1016/j. Correspondence: Dr. Dean S. Elterman, Division of Urology, University Health Network, Toronto,
ijrobp.2009.07.1748 ON, Canada; dean.elterman@uhn.ca

Urology locum position

West of the Greater Toronto area

Short-term urology locum that could lead to full-term position.
West of the Greater Toronto area; 1 in 4 on-call; reasonable expense-sharing.

Must have Ontario license and be able to start late September 2019.

Email your CV to journal@cua.org

CUAJ • August 2019 • Volume 13, Issue 8 245